Acceleration of Autoimmune Diabetes by Cyclophosphamide is Associated with an Enhanced IFN-γ Secretion Pathway
- 31 December 1999
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 13 (4) , 383-392
- https://doi.org/10.1006/jaut.1999.0331
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A cyclophosphamide-induced autoimmune diabetesThe Lancet, 1998
- Islet T Cells Secreting IFN-γ in NOD Mouse Diabetes: Arrest by p277 Peptide TreatmentJournal of Autoimmunity, 1998
- INDUCTION OF TH1 AND TH2 CD4+T CELL RESPONSES:The Alternative ApproachesAnnual Review of Immunology, 1997
- Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.Journal of Clinical Investigation, 1996
- A Simple, Sensitive, Dual mAb Based Elisa for Murine Gamma Interferon Determination: Comparison with two Common BioassaysJournal of Immunoassay, 1993
- Altered Cytokine Activity in Adjuvant Inhibition of Autoimmune DiabetesJournal of Autoimmunity, 1993
- Prevention of diabetes in NOD mice treated with antibody to murine IFNγJournal of Autoimmunity, 1991
- The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young malesJournal of Autoimmunity, 1990
- Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.The Journal of Experimental Medicine, 1989
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986